SCHEMBL19852606

SCHEMBL19852606

CN1C(=O)c2cccc(-n3c4ccccc4c4cccc(-c5cc(C#N)cc(C#N)c5)c43)c2C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 3/20 0.38
▸ DUSP3 P51452 1/20 0.36
▸ CASP3 P42574 2/20 0.36
▸ BRD1 O95696 1/20 0.35
▸ TAF1 P21675 1/20 0.35
▸ BRPF1 P55201 1/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ USP2 O75604 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ KEAP1 Q14145 2/20 0.34
▸ NFE2L2 Q16236 2/20 0.34
▸ ATM Q13315 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ PTGER4 P35408 1/20 0.34
▸ LMNA P02545 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ METAP2 P50579 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19850879 0.93 CASP3 (0.39) BRD4CASP3BRD1TAF1BRPF1
SCHEMBL23515904 0.93 BRD4 (0.42) BRD4DUSP3CASP3GABRA1GABRG2
SCHEMBL19850912 0.90 BRD4 (0.41) BRD4DUSP3CASP3MEN1USP2
SCHEMBL23516286 0.88 BRD4 (0.35) BRD4CASP3BRD1TAF1BRPF1
SCHEMBL23515897 0.88 PGR (0.39) BRD4CASP3LMNATP53MAPT
SCHEMBL23516287 0.88 PGR (0.37) BRD4CASP3BRD1TAF1BRPF1
SCHEMBL19850042 0.85 NR1H2 (0.41) DUSP3BRD1TAF1BRPF1ALDH1A1
SCHEMBL23892777 0.85 CASP3 (0.39) BRD4DUSP3CASP3MEN1USP2
SCHEMBL23516285 0.84 CASP3 (0.39) BRD4CASP3BRD1TAF1BRPF1
SCHEMBL19850803 0.84 DUSP3 (0.39) BRD4DUSP3CASP3MEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276825-B2 Organic molecules for use in organic devices CYNORA GMBH (DE) 2022-03-15 — — US disclosed
US-20210184134-A1 ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-17 — — US disclosed
EP-3279193-B1 COMPOUNDS COMPRISING A PHTHALIMIDE GROUP AND CARBAZOLE OR ITS ANALOGUES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-05-08 — — EP disclosed
WO-2018024723-A1 PHTHALIMIDE AND CARBAZOLE OR ANALOGS THEREOF CONTAINING COMPOUNDS FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210184134-A1 ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES CHRM1, C1S, DNMT3L BRD4 1051/4885DUSP3 2945/4885CASP3 2113/4885
US-11276825-B2 Organic molecules for use in organic devices AOX1, OR10J3, L1CAM BRD4 3545/4885DUSP3 4733/4885CASP3 2340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback